Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
$2.06B |
| 2 |
Nasdaq
NDAQ
|
$1.76B |
| 3 |
Wells Fargo
WFC
|
$1.1B |
| 4 |
Gilead Sciences
GILD
|
$978M |
| 5 |
Edwards Lifesciences
EW
|
$964M |
Top Sells
| 1 |
EOG Resources
EOG
|
$1.82B |
| 2 |
Apple
AAPL
|
$1.75B |
| 3 |
HCA Healthcare
HCA
|
$1.51B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$1.48B |
| 5 |
PNC Financial Services
PNC
|
$1.29B |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Healthcare | 19.6% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
NextDecade
NEXT
$2.8B
| $488K | ﹤0.01% |
+103,598
| New | +$488K |
|
1702
Solventum
SOLV
$12.6B
| $483K | ﹤0.01% |
6,933
-14,735
| -68% | -$1.03M |
|
1703
Entergy
ETR
$39.2B
| $478K | ﹤0.01% |
7,258
-27,736
| -79% | -$1.83M |
|
|
NBIS
1704
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.6B
| $477K | ﹤0.01% |
50,402
| – | – |
|
|
AGEN
1705
Agenus
AGEN
$138M
| $472K | ﹤0.01% |
86,131
-6,232
| -7% | -$34.2K |
|
1706
Akamai
AKAM
$11.3B
| $469K | ﹤0.01% |
4,650
+445
| +11% | +$44.9K |
|
1707
Lexeo Therapeutics
LXEO
$271M
| $469K | ﹤0.01% |
51,892
+29,791
| +135% | +$269K |
|
|
DADA
1708
DELISTED
Dada Nexus
DADA
| $469K | ﹤0.01% |
246,795
| – | – |
|
1709
iShares Global Energy ETF
IXC
$1.8B
| $465K | ﹤0.01% |
11,491
-253,342
| -96% | -$10.3M |
|
1710
Ocugen
OCGN
$322M
| $456K | ﹤0.01% |
+459,102
| New | +$456K |
|
1711
Energy Select Sector SPDR Fund
XLE
$26.7B
| $449K | ﹤0.01% |
5,116
-355,686
| -99% | -$31.2M |
|
1712
Jasper Therapeutics
JSPR
$44.2M
| $447K | ﹤0.01% |
+23,759
| New | +$447K |
|
1713
Henry Schein
HSIC
$8.42B
| $447K | ﹤0.01% |
6,127
-810
| -12% | -$59K |
|
1714
BCE
BCE
$23.1B
| $443K | ﹤0.01% |
12,725
+6,267
| +97% | +$218K |
|
1715
Organon & Co
OGN
$2.7B
| $437K | ﹤0.01% |
+22,858
| New | +$437K |
|
1716
Korro Bio
KRRO
$312M
| $436K | ﹤0.01% |
+13,052
| New | +$436K |
|
1717
iShares MSCI Canada ETF
EWC
$3.24B
| $435K | ﹤0.01% |
+10,477
| New | +$435K |
|
1718
Jack Henry & Associates
JKHY
$11.8B
| $435K | ﹤0.01% |
2,463
+288
| +13% | +$50.8K |
|
1719
iShares MSCI France ETF
EWQ
$383M
| $428K | ﹤0.01% |
+10,604
| New | +$428K |
|
1720
Fidelity National Financial
FNF
$16.5B
| $419K | ﹤0.01% |
6,755
-22,294
| -77% | -$1.38M |
|
1721
DaVita
DVA
$9.86B
| $407K | ﹤0.01% |
2,484
-390
| -14% | -$63.9K |
|
1722
HF Sinclair
DINO
$9.56B
| $403K | ﹤0.01% |
9,052
-1,923
| -18% | -$85.7K |
|
1723
Vanguard FTSE All-World ex-US ETF
VEU
$48.8B
| $398K | ﹤0.01% |
6,324
+230
| +4% | +$14.5K |
|
1724
Rivian
RIVN
$17.2B
| $392K | ﹤0.01% |
34,900
+4,120
| +13% | +$46.2K |
|
1725
Lear
LEA
$5.91B
| $385K | ﹤0.01% |
3,526
+143
| +4% | +$15.6K |
|